NCT02258243: Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome |
|
|
| Active, not recruiting | 2 | 3 | US | aminolevulinic acid hydrochloride, 5-ALA HCl, ALA HCl, aminolevulinic acid HCl, photodynamic therapy, Light Infusion Therapy™, PDT, therapy, photodynamic, laboratory biomarker analysis, questionnaire administration | Case Comprehensive Cancer Center, National Cancer Institute (NCI) | Basal Cell Carcinoma of the Skin, Nevoid Basal Cell Carcinoma Syndrome | 10/16 | 12/17 | | |
NCT02367547 / 2014-002746-50: Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL |
|
|
| Active, not recruiting | 1/2 | 117 | Europe | Hexylaminolevulinate cream, HAL, Hexvix, Photocure, Aminolevulinic Acid Nano Emulsion, Ameluz, Biofrontera, L01XD04, BF-200 ALA, Methylaminolevulinate cream, Metvix, Galderma, L01X D03, MAL | Joint Authority for Päijät-Häme Social and Health Care, Tampere University, University of Jyvaskyla | Neoplasms, Basal Cell, Carcinoma, Basal Cell, Photochemotherapy, Photosensitizing Agents | 09/18 | 12/25 | | |